SEIZALAM (nda209566)- (EQ 50MG BASE/10ML (EQ 5MG BASE/ML))

Generic Name	MIDAZOLAM HYDROCHLORIDE	Innovator	MMT
Dosage	EQ 50MG BASE/10ML (EQ 5MG BASE/ML)
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	SEIZALAM is a benzodiazepine indicated for the treatment of status epilepticus in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 50MG BASE/10ML (EQ 5MG BASE/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of SEIZALAM